Tau PET shows promise for early diagnosis and treatment of Alzheimer’s disease

Alzheimer’s disease, one of the most common neurodegenerative diseases, leads to progressive loss of memory and autonomy.

FDA Approves First Interchangeable Biosimilars to Aflibercept for AMD

The FDA approved the first interchangeable biosimilars to aflibercept (Eylea) to treat macular degeneration, according to an announcement from the agency. As interchangeable biosimilars, aflibercept-jbvf

May 21, 2024

Study suggests NSAIDs may lower postoperative delirium risk

Non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, may help reduce patients’ risk of postoperative delirium, according to a study presented at the ANESTHESIOLOGY® 2024 annual

October 21, 2024

Machine learning model to determine associations between metabolic syndrome and lactation

Machine learning models to investigate the relationship of lactation with metabolic syndrome risk.

February 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.